Literature DB >> 8417521

Identification of high-risk patients with left main and three-vessel coronary artery disease using stepwise discriminant analysis of clinical, exercise, and tomographic thallium data.

A S Iskandrian1, J Heo, J Lemlek, J D Ogilby.   

Abstract

This large-scale study examined the ability of stepwise discriminant analysis of clinical, exercise, and thallium tomographic data to detect high-risk patients with three-vessel or left main disease. There were 834 patients, 229 with three-vessel or left main disease (group 1) and 605 (group 2) with either two-vessel disease (n = 236), one-vessel disease (n = 195), or no coronary artery disease (n = 174). The two groups were different in age, exercise heart rate, ST segment depression during exercise, exercise systolic blood pressure, abnormal thallium scans, reversible perfusion defects, extent of thallium abnormality, number of vascular territories with perfusion abnormalities, left ventricular cavity dilatation, and increased lung thallium uptake. On multivariate stepwise discriminant analysis, only three variables were independent predictors of high risk. These included multivessel thallium abnormality (F = 107, p < 0.001), exercise heart rate (F = 27, p < 0.001), and ST segment depression (F = 8, p < 0.01). Based on these three variables, patients could be stratified into three categories with different prevalences of left main or three-vessel disease; the prevalence was 53% in 239 patients, 24% in 271 patients, and 12% in 324 patients. Thus high-risk patients with left main or three-vessel disease can be identified by exercise thallium tomographic imaging that uses a model based on stepwise discriminant analysis. The thallium data are far more powerful than the clinical or treadmill exercise data.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417521     DOI: 10.1016/0002-8703(93)90078-n

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Diagnostic and prognostic applications for vasodilator stress myocardial perfusion imaging and the importance of radiopharmaceutical selection.

Authors:  R C Hendel
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  Identification of advanced coronary artery disease with exercise myocardial perfusion imaging: the clinical value of a novel approach for assessing lung thallium-201 uptake.

Authors:  Efstratios Moralidis; Tryfon Spyridonidis; Georgios Arsos; Constantinos Anagnostopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-23       Impact factor: 9.236

3.  Quantification of left ventricular size on exercise thallium-201 single-photon emission tomography.

Authors:  C Kurata; Y Wakabayashi; S Shouda; T Mikami; K Tawarahara
Journal:  Eur J Nucl Med       Date:  1996-07

4.  Comparison of the treadmill exercise score and single-photon emission computed tomographic thallium imaging in risk assessment.

Authors:  A S Iskandrian; J Johnson; T T Le; V Wasserleben; V Cave; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 5.  Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging.

Authors:  A E Iskandrian; J Heo; N Nallamothu
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

6.  Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT.

Authors:  K T Ho; T D Miller; T F Christian; D O Hodge; R J Gibbons
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

7.  Improved detection of left main coronary artery disease with attenuation-corrected SPECT.

Authors:  C S Duvernoy; E P Ficaro; M Z Karabajakian; P A Rose; J R Corbett
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 8.  Clinical review of attenuation-corrected cardiac SPECT.

Authors:  J R Corbett; E P Ficaro
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

9.  Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.

Authors:  Gregorino Paone; Alvaro Leone; Sandro Batzella; Vittoria Conti; Francesco Belli; Laura De Marchis; Alice Mannocci; Giovanni Schmid; Claudio Terzano
Journal:  Inflamm Res       Date:  2012-12-23       Impact factor: 4.575

10.  Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease.

Authors:  J E Karlsson; A Björkholm; E Nylander; J Ohlsson; L Wallentin
Journal:  Int J Card Imaging       Date:  1995-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.